November 21, 2025, Copenhagen – We are pleased to announce the publication of our new white paper, “Advancing Neonatal Screening with gMendel®’s Next-Generation Genomic Technology,” along with its appendix, “Economic Break-Even Analysis for National Genomic NBS Implementation.”
Our CTO, Zoran Velkoski, notes:
“Our targeted genomic approach reduces complexity and operational overhead while delivering faster results, significantly lower costs, enhanced data privacy, fewer ambiguous variants, and dramatically reduced energy and storage requirements.”
You can access the full white paper and appendix here.